Baird Financial Group, Inc. Eli Lilly & CO Transaction History

Baird Financial Group, Inc.

$50.2 Billion
Q3 2024

A detailed history of Baird Financial Group, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Baird Financial Group, Inc. holds 276,068 shares of LLY stock, worth $220 Million. This represents 0.49% of its overall portfolio holdings.

Number of Shares

276,068

Previous 262,606 5.13%

Holding current value

$220 Million

Previous $238 Million 2.87%

% of portfolio

0.49%

Previous 0.5%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$772.14 - $960.02 $10.4 Million - $12.9 Million	13,462 Added 5.13%	276,068 $245 Million
Q2 2024 Aug 13, 2024	BUY	$724.87 - $909.04 $18.1 Million - $22.7 Million	24,979 Added 10.51%	262,606 $238 Million
Q1 2024 May 14, 2024	BUY	$592.2 - $792.28 $6.5 Million - $8.69 Million	10,974 Added 4.84%	237,627 $185 Million
Q4 2023 Feb 14, 2024	BUY	$525.19 - $619.13 $5.84 Million - $6.89 Million	11,124 Added 5.16%	226,653 $132 Million
Q3 2023 Nov 13, 2023	BUY	$434.7 - $599.3 $6.37 Million - $8.78 Million	14,653 Added 7.29%	215,529 $116 Million
Q2 2023 Aug 11, 2023	SELL	$350.74 - $468.98 $9.84 Million - $13.2 Million	-28,058 Reduced 12.26%	200,876 $94.2 Million
Q1 2023 May 15, 2023	BUY	$310.63 - $364.82 $1.39 Million - $1.63 Million	4,478 Added 2.0%	228,934 $78.6 Million
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $3.14 Million - $3.58 Million	-10,601 Reduced 4.61%	219,377 $70.9 Million
Q2 2022 Aug 08, 2022	SELL	$278.73 - $327.27 $7.76 Million - $9.11 Million	-27,832 Reduced 10.8%	229,978 $74.6 Million
Q1 2022 May 13, 2022	SELL	$234.69 - $291.66 $1.37 Million - $1.7 Million	-5,819 Reduced 2.21%	257,810 $73.8 Million
Q4 2021 Feb 09, 2022	BUY	$224.85 - $279.04 $1.43 Million - $1.78 Million	6,376 Added 2.48%	263,629 $72.8 Million
Q3 2021 Nov 12, 2021	SELL	$221.6 - $272.71 $1.17 Million - $1.44 Million	-5,269 Reduced 2.01%	257,253 $59.4 Million
Q2 2021 Aug 11, 2021	SELL	$180.55 - $233.54 $36,832 - $47,642	-204 Reduced 0.08%	262,522 $60.3 Million
Q1 2021 May 13, 2021	SELL	$164.32 - $212.72 $2.35 Million - $3.05 Million	-14,322 Reduced 5.17%	262,726 $49.1 Million
Q4 2020 Feb 11, 2021	BUY	$130.46 - $172.63 $1.02 Million - $1.35 Million	7,832 Added 2.91%	277,048 $46.8 Million
Q3 2020 Nov 12, 2020	BUY	$146.22 - $169.13 $2.36 Million - $2.73 Million	16,142 Added 6.38%	269,216 $39.8 Million
Q2 2020 Oct 22, 2020	SELL	$136.42 - $164.18 $1.3 Million - $1.56 Million	-9,530 Reduced 3.63%	253,074 $41.6 Million
Q2 2020 Aug 14, 2020	SELL	$136.42 - $164.18 $601,475 - $723,869	-4,409 Reduced 1.65%	262,604 $36.7 Million
Q1 2020 May 14, 2020	SELL	$119.05 - $147.35 $1.75 Million - $2.16 Million	-14,668 Reduced 5.21%	267,013 $37 Million
Q4 2019 Feb 14, 2020	BUY	$106.92 - $132.43 $86,819 - $107,533	812 Added 0.29%	281,681 $37 Million
Q3 2019 Nov 14, 2019	SELL	$106.79 - $116.16 $28,406 - $30,898	-266 Reduced 0.09%	280,869 $31.4 Million
Q2 2019 Aug 14, 2019	BUY	$110.79 - $129.32 $8.1 Million - $9.46 Million	73,153 Added 35.17%	281,135 $31.1 Million
Q1 2019 May 14, 2019	SELL	$111.31 - $131.02 $163,069 - $191,944	-1,465 Reduced 0.7%	207,982 $27 Million
Q4 2018 Feb 14, 2019	BUY	$105.9 - $118.64 $1.76 Million - $1.98 Million	16,666 Added 8.65%	209,447 $24.2 Million
Q3 2018 Nov 13, 2018	BUY	$85.86 - $107.31 $2.94 Million - $3.68 Million	34,253 Added 21.61%	192,781 $20.7 Million
Q2 2018 Aug 13, 2018	SELL	$75.7 - $86.88 $2.26 Million - $2.59 Million	-29,808 Reduced 15.83%	158,528 $13.5 Million
Q1 2018 May 14, 2018	SELL	$74.21 - $87.6 $5.25 Million - $6.19 Million	-70,702 Reduced 27.29%	188,336 $14.6 Million
Q4 2017 Feb 09, 2018	SELL	$81.94 - $87.89 $578,824 - $620,854	-7,064 Reduced 2.65%	259,038 $21.9 Million
Q3 2017 Nov 14, 2017	SELL	$77.07 - $85.54 $69,363 - $76,986	-900 Reduced 0.34%	266,102 $22.8 Million
Q2 2017 Aug 14, 2017	BUY	N/A	267,002	267,002 $22 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baird Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Baird Financial Group, Inc. with notifications on news.

Account

Baird Financial Group, Inc. Eli Lilly & CO Transaction History